Daily Sepsis Research Analysis
Analyzed 10 papers and selected 3 impactful papers.
Summary
Three studies advance sepsis science across mechanisms, diagnostics, and prognosis. A mechanistic mouse study identifies S1PR4 as a regulator restraining platelet fibrinogen binding and disseminated intravascular coagulation in sepsis. Clinically, a neonatal diagnostic study suggests VersaTREK improves pathogen detection with very low blood volumes, and an ICU cohort shows early urine output trajectories predict mortality and acute kidney injury.
Research Themes
- Sepsis coagulopathy mechanisms via S1P–S1PR4 signaling
- Neonatal sepsis diagnostics with low-volume blood cultures
- Dynamic urine output trajectories for ICU prognosis
Selected Articles
1. Sphingosine-1-phosphate regulates platelet fibrinogen binding via sphingosine-1-phosphate receptor type 4.
Using a murine sepsis (CASP) model, the authors show that S1PR4 restrains platelet fibrinogen binding and preserves organized thrombus formation. S1PR4 deficiency increased DIC incidence, shortened clotting time, and enlarged clot size, implicating S1P–S1PR4 signaling as a brake on sepsis-associated coagulopathy.
Impact: Reveals a receptor-specific mechanism linking lipid signaling to sepsis coagulopathy, identifying S1PR4 as a potential therapeutic target to mitigate DIC.
Clinical Implications: Modulating S1PR4 activity could attenuate platelet hyperreactivity and DIC in sepsis. These data also inform safety considerations for drugs targeting S1P pathways in critically ill patients.
Key Findings
- S1PR4-deficient mice exhibited increased DIC in the CASP sepsis model.
- Platelets lacking S1PR4 showed excessive fibrinogen binding and disorganized thrombus formation relative to wild-type.
- Rotational thromboelastometry demonstrated shortened clotting time and increased clot size with S1PR4 deficiency.
Methodological Strengths
- In vivo sepsis model (CASP) with phenotypic coagulation outcomes
- Multi-modal assessment (platelet function assays, thrombus formation imaging, rotational thromboelastometry)
Limitations
- Preclinical murine study without human validation
- Downstream signaling pathways of S1PR4 not fully delineated
Future Directions: Validate S1PR4 function and expression in human sepsis, and test selective S1PR4 modulators in preclinical sepsis and DIC models.
INTRODUCTION: Sphingosine-1-phosphate (S1P) is a bioactive signalling sphingolipid secreted by platelets during activation. Platelets express distinct S1P receptors on their surface, and a comprehensive understanding of their effects is yet to be achieved. Here, we describe the regulation of fibrinogen binding in activated platelets via S1P receptor type 4 (S1PR METHODS: Thrombus formation and platelet function in an S1pr RESULTS: In the Colon Ascendens Stent Peritonitis (CASP) model, an increased incidence of disseminated intravascular coagulation (DIC) was observed in S1PR4-deficient mice. Murine platelets from S1PR4-deficient mice showed excessive fibrinogen binding and disorganised thrombus formation compared to wild-type platelets. Rotational thromboelastometry confirmed this result, showing a shortened clotting time and an increased clot size in S1PR CONCLUSION: These findings strongly suggest that S1P signalling via S1PR
2. Analysis and comparison of the difference between two major blood culture system in the laboratory and neonatal intensive care unit.
Across in vitro, prospective NICU cohort, and head-to-head phases, VersaTREK matched or outperformed BD, particularly at low bacterial loads and with minimal blood volumes (as low as 0.1 mL). This supports its utility for diagnosing neonatal sepsis when blood volume is limited.
Impact: Addresses a key diagnostic bottleneck in neonatal sepsis—limited blood volume—by demonstrating reliable detection performance at very low volumes.
Clinical Implications: In NICUs, adopting systems capable of aerobic and anaerobic culture with minimal sample volume may improve pathogen detection and antimicrobial stewardship in ELBW infants.
Key Findings
- VersaTREK outperformed BD at low bacterial loads in vitro.
- In a prospective NICU cohort, VersaTREK yielded higher detection rates, especially for Gram-positive cocci and Gram-negative bacteria.
- Head-to-head comparison showed overall comparable performance, with advantages for VersaTREK when blood volume was as low as 0.1 mL.
Methodological Strengths
- Three-phase design integrating in vitro, prospective cohort, and head-to-head comparisons
- Direct assessment of performance under minimal blood volume conditions
Limitations
- Sample sizes not detailed; larger studies needed to confirm findings
- Time-to-positivity and clinical outcome impacts were not reported
Future Directions: Conduct multicenter prospective studies to compare time-to-positivity, contamination rates, cost-effectiveness, and clinical outcomes, especially in ELBW infants.
BACKGROUND: Neonatal sepsis is a critical health concern that demands accurate and timely diagnosis. Blood culture, the gold standard, is challenging in extremely low birth weight (ELBW) infants because of the limited blood volume and potential aerobic culture limitations. The VersaTREK (Thermo Fisher Scientific, Waltham, MA, USA) blood culture system, which requires less blood and offers both aerobic and anaerobic cultures, presents a potential solution. This study aimed to compare the diagnostic performance with the widely used BD (Becton Dickinson, Franklin Lakes, NJ, USA) blood culture systems for neonatal sepsis patients. METHODS: We conducted a three-step study, including in vitro testing of common pathogens, prospective observational cohort data from a neonatal intensive care unit (NICU), and a head-to-head comparison. VersaTREK's blood culture bottles include aerobic and anaerobic media, whereas BD uses a specialized bottle for aerobic cultures. RESULTS: In phase 1 of this in vitro comparison study, VersaTREK outperformed BD, particularly at low bacterial loads. In phase 2, a prospective observational cohort analysis revealed a significantly greater yield with VersaTREK, especially for gram-positive cocci and gram-negative bacteria. In phase 3, a head-to-head comparison demonstrated comparable performance between the two systems, with potential advantages for VersaTREK in scenarios involving minimal blood volumes, as little as 0.1 mL. CONCLUSIONS: The VersaTREK and BD blood culture systems demonstrated similar diagnostic performance, with VersaTREK capable of detecting as little as 0.1 mL of blood. While this is promising in scenarios with minimal blood volume, further investigations with larger sample sizes are needed.
3. The impact of urine output trajectory on clinical outcomes in female patients with genitourinary infections in the intensive care unit.
In 1,289 female ICU patients with genitourinary infections, four early urine output trajectories were identified. Persistently low or declining trajectories were associated with markedly higher 28-day mortality (HR up to 4.329) and higher AKI incidence versus a low-to-high trajectory.
Impact: Introduces dynamic urine output trajectories as a pragmatic early prognostic tool, moving beyond static thresholds to stratify risk in ICU patients with infection.
Clinical Implications: Incorporating early urine output trajectories into ICU monitoring could identify high-risk patients for AKI and mortality, prompting earlier hemodynamic optimization and nephroprotective strategies.
Key Findings
- Four urine output trajectory classes in the first 3 ICU days: persistently low (65.7%), high-to-low (13.7%), persistently high (4.0%), low-to-high (16.7%).
- Compared with low-to-high, 28-day mortality risk increased progressively: HR 4.329 (persistently low), 3.477 (high-to-low), 2.081 (persistently high).
- Persistently low trajectory was associated with higher incidence of AKI versus low-to-high.
Methodological Strengths
- Latent class growth modeling to capture dynamic trajectories
- Multivariable adjustment to account for confounders
Limitations
- Retrospective single-population cohort (female ICU patients) limits generalizability
- Potential residual confounding and lack of external validation
Future Directions: Externally validate trajectory-based risk models and test whether trajectory-informed interventions improve outcomes.
Genitourinary infections are common in female intensive care unit patients and are associated with acute kidney injury and sepsis, often becoming life-threatening. Although urine volume correlates with these adverse outcomes, the prognostic value of dynamic urine output trajectories remains unclear. This study investigates the relationship between early urine output trajectories and clinical outcomes in female with genitourinary infections. A retrospective cohort of 1289 patients were analyzed. Latent class growth modeling identified distinct urine output trajectories in the first 3 days after intensive care unit admission. The primary endpoint was 28-day mortality, and the secondary outcome was the incidence of acute kidney injury. Four trajectory classes were identified: Class 1-persistently low (65.7%), Class 2-high-to-low (13.7%), Class 3-persistently high (4.0%), and Class 4-low-to-high (16.7%). In multivariable analysis, compared to Class 4, the 28-day mortality risk showed a graded increase with hazard ratio of 4.329 for Class 1, 3.477 for Class 2, and 2.081 for Class 3. Additionally, Class 1 was associated with a significantly higher incidence of acute kidney injury compared to Class 4. The trajectory of urine output changes in female patients with genitourinary infections is a potential variable in predicting mortality and acute kidney injury outcomes.